Abstract: A computing device generates synthetic tabular data.

Abstract: Disclosed herein are materials and a micro-LED display with carbon-based light-emitting materials, carbon quantum dots, that are made by a solvothermal synthesis of a mixture of aromatic amino acid, 3,4-dihydroxy-L-phenylalanine (LDOPA), and urea in dimethylformamide (DMF). The mixture is heated in a sealed pressure reactor at a temperature, ranging from 120 degrees Celsius to 350 degrees Celsius, for 4-24 hours. The product is then purified to collect the solid powder. The purified CDs can be dissolved in an acrylate monomer solution or a polymer solution for material delivery and curing process on a target substrate for the applications, including light-emitting devices or sensors.

Abstract: Provided are a transaminase mutant and a method for producing a chiral amine using the same. An amino acid sequence of the transaminase mutant is an amino acid sequence obtained by mutation occurred in an amino acid sequence as shown in SEQ ID NO: 1, and the mutation includes at least one of the following mutation sites: position 3, position 5, position 8, position 25, position 32, position 45, position 56, position 59, position 60, position 84, position 86, position 164, position 176, position 178, position 180, position 187, position 197, position 206, position 207, position 242, position 245, position 319 and position 324.

Abstract: Novel superoxide dismutases of fungal origin are active, gastric stable and thermal stable, and effective for use in animal feed additives. The use of superoxide dismutase in animal feed improve animal growth, animal health and intestinal health of animals.

Abstract: Disclosed herein are methods and compositions for treating or preventing bacterial infection. In particular, the methods and compositions are directed towards C. difficile infection. In particular aspects, the compositions are vaccines containing multimeric polypeptides containing portions of multiple toxins from bacteria. The polypeptides induce effective immune responses thus treating or preventing infection.

Abstract: Provided are methods and compositions for the delivery of fully human post-translationally modified therapeutic monoclonal antibodies and antigen-binding fragments thereof. The fully human post-translationally modified therapeutic monoclonal antibodies may be delivered by gene therapy methods, e.g., as a recombinant adeno-associated vims (rAAV) vector to the appropriate tissue. Methods of manufacture of the AAV vectors, pharmaceutical compositions and methods of treatment are also provided. In addition, provided are methods of producing therapeutic antibodies that are “biobetters” as fully human post-translationally modified. These fully human post-translationally modified therapeutic antibodies may be administered to a subject in need of treatment with the therapeutic antibody.

Abstract: Disclosed herein are nanoparticles suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.

Abstract: Novel polypeptides of fungal origin with catalase active are active, gastric stable and thermal stable, and effective for use in animal feed additives.

Abstract: The present invention relates to recombinant adeno-associated viruses (rAAVs) having capsid proteins engineered to include amino acid sequences that confer and/or enhance desired properties. In particular, the invention provides engineered capsid proteins comprising peptide insertions from heterologous proteins inserted within or near variable region IV (VR-IV) of the virus capsid, such that the insertion is surface exposed on the AAV particle. The invention also provides capsid proteins that direct rAAVs to target tissues, in particular, capsid proteins comprising peptides derived from erythropoietin or dynein that are inserted into surface-exposed variable regions and that target rAAVs to retinal tissue and/or neural tissue, including the central nervous system, and deliver therapeutics for treating neurological and/or eye disorders.

Abstract: A method, an apparatus, and an electronic device for data processing, and a computer-readable storage medium are provided. The method includes: generating unique identification information associated with a user account; transmitting the unique identification information to the user account; receiving, from a server associated with an institution which verifies identity information corresponding to the user account, the unique identification information and a non-payment service request related to the user account; and identifying the user account based on the unique identification information, and providing the user account with a non-payment service based on the non-payment service request.

Abstract: Example signal sending methods and apparatus are described. One example method includes obtaining a first insertion loss corresponding to a first resource and a second insertion loss corresponding to a second resource, where the first insertion loss is different from the second insertion loss. A first transmit power corresponding to the first resource is determined based on the first insertion loss. A second transmit power corresponding to the second resource is determined based on the second insertion loss. A first signal is sent on the first resource based on the first transmit power. A second signal is sent on the second resource based on the second transmit power.

Abstract: The present invention relates to a method for producing a protein hydrolysate using a polypeptide having endopeptidase activity and a polypeptide having carboxypeptidase activity and the use of these enzymes for hydrolysing a protein substrate. In addition, the present invention relates to polypeptides having carboxypeptidase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

Abstract: The disclosure relates to wastewater treatment technologies, and particularly to an adsorbent and its preparation method and application. The adsorbent includes titanium hexametaphosphate; the titanium hexametaphosphate is mainly prepared from hexametaphosphate and titanium salt. The adsorbent is an aggregate of micron or nanometer particles, with a large surface area and a good adsorption performance. The adsorbent, as a wastewater treatment agent, may effectively remove thallium contaminants in various water bodies such as underground water, surface water, chemical wastewater and mine wastewater at a removal rate of 99.8%; and the adsorbent has a good removal capability for heavy metals in water such as cadmium, plumbum, copper, stibium, cesium and uranium. The adsorbent has a wide applicable PH value range, and especially has a good adsorption capacity, stability and heat resistance under acidic conditions. The preparation method is simple to operate, low in reaction condition requirements and low in cost.